| Heart disease and stroke statistics—2016 update: a report from the American Heart Association D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ... circulation 133 (4), e38-e360, 2016 | 62719* | 2016 |
| 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) The … G Hindricks, T Potpara, N Dagres, E Arbelo, JJ Bax, ... European heart journal 42 (5), 373-498, 2021 | 9163 | 2021 |
| Edoxaban versus warfarin in patients with atrial fibrillation RP Giugliano, CT Ruff, E Braunwald, SA Murphy, SD Wiviott, JL Halperin, ... New England Journal of Medicine 369 (22), 2093-2104, 2013 | 5897 | 2013 |
| 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with … Authors/Task Force Members, SG Priori, C Blomström-Lundqvist, ... Ep Europace 17 (11), 1601-1687, 2015 | 5344 | 2015 |
| 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of … Authors/Task Force Members, M Brignole, A Auricchio, G Baron-Esquivias, ... European heart journal 34 (29), 2281-2329, 2013 | 3763 | 2013 |
| The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation J Steffel, P Verhamme, TS Potpara, P Albaladejo, M Antz, L Desteghe, ... European heart journal 39 (16), 1330-1393, 2018 | 3216 | 2018 |
| European Society of Cardiology: cardiovascular disease statistics 2019 A Timmis, N Townsend, CP Gale, A Torbica, M Lettino, SE Petersen, ... European heart journal 41 (1), 12-85, 2020 | 2642 | 2020 |
| Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation H Heidbuchel, P Verhamme, M Alings, M Antz, HC Diener, W Hacke, ... Ep Europace 17 (10), 1467-1507, 2015 | 1753 | 2015 |
| 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European … M Glikson, JC Nielsen, MB Kronborg, Y Michowitz, A Auricchio, ... EP Europace 24 (1), 71-164, 2022 | 1658 | 2022 |
| 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology … AR Lyon, T López-Fernández, LS Couch, R Asteggiano, MC Aznar, ... European Heart Journal-Cardiovascular Imaging 23 (10), e333-e465, 2022 | 1297 | 2022 |
| Efficacy of implantable cardioverter–defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy BJ Maron, WK Shen, MS Link, AE Epstein, AK Almquist, JP Daubert, ... New England Journal of Medicine 342 (6), 365-373, 2000 | 1250 | 2000 |
| Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy BJ Maron, P Spirito, WK Shen, TS Haas, F Formisano, MS Link, ... Jama 298 (4), 405-412, 2007 | 930 | 2007 |
| Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report GYH Lip, A Banerjee, G Boriani, C en Chiang, R Fargo, B Freedman, ... Chest 154 (5), 1121-1201, 2018 | 892 | 2018 |
| Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a … Task Force Members, GYH Lip, S Windecker, K Huber, P Kirchhof, ... European heart journal 35 (45), 3155-3179, 2014 | 675 | 2014 |
| Screening for atrial fibrillation: a report of the AF-SCREEN International Collaboration B Freedman, J Camm, H Calkins, JS Healey, M Rosenqvist, J Wang, ... Circulation 135 (19), 1851-1867, 2017 | 607 | 2017 |
| Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial P Ponikowski, BA Kirwan, SD Anker, T McDonagh, M Dorobantu, ... The Lancet 396 (10266), 1895-1904, 2020 | 591 | 2020 |
| 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing BL Wilkoff, L Fauchier, MK Stiles, CA Morillo, SM Al-Khatib, J Almendral, ... EP Europace 18 (2), 159-183, 2016 | 470 | 2016 |
| Device-detected atrial fibrillation and risk for stroke: an analysis of> 10 000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation … G Boriani, TV Glotzer, M Santini, TM West, M De Melis, M Sepsi, ... European heart journal 35 (8), 508-516, 2014 | 468 | 2014 |
| Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events GL Botto, L Padeletti, M Santini, A Capucci, M Gulizia, F Zolezzi, S Favale, ... Journal of cardiovascular electrophysiology 20 (3), 241-248, 2009 | 468 | 2009 |
| Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers A Capucci, M Santini, L Padeletti, M Gulizia, GL Botto, G Boriani, R Ricci, ... Journal of the American College of Cardiology 46 (10), 1913-1920, 2005 | 448 | 2005 |
Gregory LipUniversity of Liverpool, United Kingdom; Aalborg University, Denmark在 liverpool.ac.uk 的电子邮件经过验证
